Infectious Disease Puscast

Infectious Disease Puscast #76

Mar 19, 2025 · 46 min · Episode 76 · 28.4 MB
0:00-46:55

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

On episode #76 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 2/27/25 – 3/12/25.

Hosts: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode
  • Viral
  • Trends in respiratory pathogen testing at us children's hospitals (JAMA Network)
  • Changes in respiratory viral testing before and after the covid-19 pandemic(JAMA Network)
  • Expanding measles outbreak in the United States and guidance for the upcoming travel season (CDC Emergerncy Preparedness and Response)
  • Measles cases and outbreaks (CDC Measles (Rubeola))
  • Facts and myths about measles (LANCET: Infectious Diseases)
  • Protective effects of recombinant zoster vaccine and antiviral therapy against cardiovascular disease following herpes zoster infection (JID)
  • Chikungunya vaccine information for healthcare providers (CDC Chikungunya Virus)
  • Factors to assess when considering use of chikungunya vaccine(CDC)
  • Bacterial
  • Should patients hospitalized forcommunity-acquired pneumonia be treated with additional antimicrobial agents directed against anaerobes? (American Journal of Therapeutics)
  • Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy(Blood)
  • Effectiveness of ampicillin/sulbactam versus ceftriaxone for the initial treatment of community-acquired pneumonia in older adults: a target trial emulation study(OFID)
  • Male-partner treatment to prevent recurrence of bacterial vaginosis(NEJM)
  • Fungal
  • The Last of US Season 2 (YouTube)
  • Activity of rezafungin against echinocandin non–wild type candida glabrata clinical isolates from a global surveillance program (OFID)
  • Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study (Intensive Care Medicine)
  • Parasitic
  • Human alveolar echinococcosis – global, regional and national annual incidence and prevalence rates (CMI: Clinical Microbiology and Infection)
  • Dust to Diagnosis – with MSGERC (FEBRILE)
  • The clinical picture caused by Fasciola gigantica: Analysis of 3,250 patients along the 1995–2019 countrywide spread in Vietnam (OFID)
  • Miscellaneous
  • Reprint of: From medical editors: a call to the global infectious diseases and clinical microbiology community (CMI: Clinical Microbiology and Infection)
  • A hot topic: A climate-focused track for infectious disease fellowship (OFID)
  • Are we being gaslit? A primer for recognizing corporate jargon to overcome gaslighting for the infectious disease workforce (CID)

Music is by Ronald Jenkees

Information on this podcast should not be considered as medical advice.